Cargando…
Peptides to Tackle Leishmaniasis: Current Status and Future Directions
Peptide-based drugs are an attractive class of therapeutic agents, recently recognized by the pharmaceutical industry. These molecules are currently being used in the development of innovative therapies for diverse health conditions, including tropical diseases such as leishmaniasis. Despite its soc...
Autores principales: | Robles-Loaiza, Alberto A., Pinos-Tamayo, Edgar A., Mendes, Bruno, Teixeira, Cátia, Alves, Cláudia, Gomes, Paula, Almeida, José R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122823/ https://www.ncbi.nlm.nih.gov/pubmed/33922379 http://dx.doi.org/10.3390/ijms22094400 |
Ejemplares similares
-
Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity
por: Robles-Loaiza, Alberto A., et al.
Publicado: (2022) -
A Review of Leishmaniasis: Current Knowledge and Future Directions
por: Mann, Sarah, et al.
Publicado: (2021) -
Disclosure of a Promising Lead to Tackle Complicated Skin and Skin Structure Infections: Antimicrobial and Antibiofilm Actions of Peptide PP4-3.1
por: Gomes, Ana, et al.
Publicado: (2021) -
Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
por: Haldar, Arun Kumar, et al.
Publicado: (2011) -
Leishmaniasis and glycosaminoglycans: a future therapeutic strategy?
por: Merida-de-Barros, Débora Almeida, et al.
Publicado: (2018)